Lv1
30 积分 2024-10-24 加入
A Broad Spectrum of Possibilities: Spectrum Scores as a Unifying Metric of Antibiotic Utilization
1天前
待确认
Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study
9天前
已完结
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
3个月前
已完结
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
4个月前
已完结
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
4个月前
已完结
Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem)
4个月前
已关闭
Therapeutic effectiveness of a generic versus original meropenem in serious infections
4个月前
已关闭
Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis
4个月前
已完结
Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers
5个月前
已完结
Vancomycin-induced linear IgA bullous dermatosis
5个月前
已关闭
皖公网安备34019202002308
